Richter Nyrt News
-
Gedeon Richter Nyrt., Hungary’s biggest drugmaker, reported a first-quarter profit that beat analyst estimates as the company shifts its focus to China and the former Soviet Union while sales in the U.S. decline.
-
OTP Bank Nyrt., Hungary’s largest lender, will have its weighting increased in the country’s benchmark index from Oct. 1 as part of the Budapest Stock Exchange’s semi-annual review.
-
Egis Nyrt., the Hungarian drugmaker owned by Laboratoires Servier, jumped the most in 14 months after fiscal first-quarter results beat estimates.
-
Gedeon Richter Nyrt., Hungary’s biggest drugmaker, advanced for the first time in four days after announcing a joint venture to expand sales in China.
-
Emerging-market stocks fell for a sixth day, the longest losing streak since July, on prospects China’s new leadership will put off policy changes needed to reform the economy. Volcan Cia. Minera SAA led declines after MSCI Inc. removed the mining company from its Peru index.
-
Gedeon Richter Nyrt., Hungary’s biggest drugmaker, fell to the lowest in almost six months before the stock is dropped from MSCI Inc.’s Hungarian index at the end of this month.
-
Gedeon Richter Nyrt., Hungary’s biggest drugmaker, dropped for a second day as fourth-quarter sales and operating results came in below analysts’ estimates.
-
Hungary’s BUX Index rose 654.99, or 3.7 percent, to 18,475.14 by 4:42 p.m. in Budapest, the highest level since Oct. 3.
-
Hungary’s benchmark BUX stock index fell 0.6 percent to 19,034.64 as of 11:19 a.m. in Budapest. The following are among the most active equities in the Hungarian market today. Stock symbols follow company names.
-
Hungary’s stock index fell, paring this week’s advance as OTP Bank Nyrt., oil refiner Mol Nyrt. and drugmaker Gedeon Richter Nyrt. slid more than 1.7 percent.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page